PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportspancreatic neoplasms
MeSH D010190 - pancreatic neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010182:Pancreatic diseases
0 Companies
0 Drugs
Success rate
D004067:Digestive system neoplasms
0 Companies
0 Drugs
Success rate
D004701:Endocrine gland neoplasms
0 Companies
0 Drugs
Success rate
D010190: 
Pancreatic neoplasms
D000077779:Pancreatic intraductal neoplasms
0 Companies
0 Drugs
Success rate
D007516:Islet cell adenoma
0 Companies
0 Drugs
Success rate
D018273:Islet cell carcinoma
$
Success rate
D021441:Pancreatic ductal carcinoma
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaFluorouracil Adrucil  1991-10-18   
Docetaxel Docetaxel  2015-09-16   
Docetaxel Docetaxel Teva  2010-01-26   
Docetaxel Docetaxel Teva Pharma  2011-01-21   
Fluorouracil Fluorouracil  2000-01-27   
Ifosfamide Ifosfamide/mesna  2002-02-26   
Sunitinib Sunitinib  2021-11-30   
Tamoxifen Tamoxifen  2003-04-28   
Octreotide Octreotide  2023-12-05   
Irinotecan Irinotecan  2008-02-27   
Novast LaboratoriesFluorouracil Fluorouracil  2019-12-12   
Docetaxel Docetaxel  2017-08-31   
Irinotecan Irinotecan  2017-05-26   
Taro PharmaceuticalFluorouracil Fluorouracil  2003-11-05   
IngenusDocetaxel Docetaxel 2036-03-14 2022-11-22   
MylanDocetaxel Docetaxel  2023-05-11   
Docetaxel Docetaxel Mylan  2012-01-31   
Octreotide Octreotide  2011-02-10   
Sunitinib Sunitinib  2021-12-06   
Tamoxifen Tamoxifen  2003-02-20   
Rising PharmaceuticalsFluorouracil Fluorouracil  2015-04-20   
Ifosfamide Ifosfamide  2012-11-26   
Mayne GroupTamoxifen Soltamox  2005-10-29   
RocheErlotinib Tarceva  2005-09-19 $180.177 M Y2020 
SandozDocetaxel Docetaxel  2011-06-29   
Fluorouracil Fluorouracil  2011-05-02   
Irinotecan Irinotecan  2008-02-27   
AstraZenecaTamoxifen Nolvadex  1982-01-01   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
70%
184/261
Phase 2
22%
62/282
Phase 3
34%
30/88
Approved: 11Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Roche
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use